Literature DB >> 20977364

Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and disease processes.

Giles E Hardingham1, Stuart A Lipton.   

Abstract

Oxidative/nitrosative stress contributes to the etiology of many neurological disorders in the developing and aged/mature central nervous system, including acute trauma such as ischemia and hyperoxia, as well as chronic diseases such as Alzheimer's and Parkinson's diseases. In addition to the accumulation of nonspecific oxidative damage, it is becoming clear that pathological conditions lead to the oxidative/nitrosative modification of specific proteins, including those involved in apoptosis, proteolysis, and protein (mis)folding. Several disorders, including stroke and Parkinson's disease, are associated with inactivating modifications of antioxidant enzymes themselves, thus compromising antioxidant defenses. Conversely, neuroprotective pathways, such as neurotrophin- and synaptic activity-induced signals, can upregulate key antioxidant systems, potentially contributing to the cytoprotective actions of adaptive stress responses following exercise or calorie-restriction. On the flip-side, hypofunction of these pathways is associated with the death of developing neurons. An increased knowledge of how neuronal antioxidant systems are controlled in health and disease is unearthing therapeutic targets in several disorders. Moreover, the emerging importance of master regulators of antioxidant defenses such as nuclear factor-erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) is revealing ways through which intrinsic defenses may be manipulated to combat oxidative/nitrosative stress. Such approaches offer an alternative strategy to classical antioxidant interventions based on the administration of free radical scavengers and spin-traps.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20977364     DOI: 10.1089/ars.2010.3573

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  27 in total

1.  Stroke research at a crossroad: asking the brain for directions.

Authors:  Costantino Iadecola; Josef Anrather
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

Review 2.  The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease.

Authors:  Yash B Joshi; Phillip F Giannopoulos; Domenico Praticò
Journal:  Trends Pharmacol Sci       Date:  2015-02-20       Impact factor: 14.819

Review 3.  Pathogenic mechanisms following ischemic stroke.

Authors:  Seyed Esmaeil Khoshnam; William Winlow; Maryam Farzaneh; Yaghoob Farbood; Hadi Fathi Moghaddam
Journal:  Neurol Sci       Date:  2017-04-17       Impact factor: 3.307

Review 4.  Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.

Authors:  Takumi Satoh; Scott R McKercher; Stuart A Lipton
Journal:  Free Radic Biol Med       Date:  2013-07-25       Impact factor: 7.376

5.  Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.

Authors:  H Karatas; Joo Eun Jung; E H Lo; K van Leyen
Journal:  Brain Res       Date:  2017-10-24       Impact factor: 3.252

6.  Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.

Authors:  Kazim Yigitkanli; Anton Pekcec; Hulya Karatas; Stefanie Pallast; Emiri Mandeville; Netra Joshi; Natalya Smirnova; Irina Gazaryan; Rajiv R Ratan; Joseph L Witztum; Joan Montaner; Theodore R Holman; Eng H Lo; Klaus van Leyen
Journal:  Ann Neurol       Date:  2012-11-28       Impact factor: 10.422

Review 7.  Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis.

Authors:  Giles E Hardingham; Kim Q Do
Journal:  Nat Rev Neurosci       Date:  2016-01-14       Impact factor: 34.870

8.  γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor.

Authors:  Ruben Quintana-Cabrera; Seila Fernandez-Fernandez; Veronica Bobo-Jimenez; Javier Escobar; Juan Sastre; Angeles Almeida; Juan P Bolaños
Journal:  Nat Commun       Date:  2012-03-06       Impact factor: 14.919

9.  Ageing of enteric neurons: oxidative stress, neurotrophic factors and antioxidant enzymes.

Authors:  Kris Korsak; Nazanin F Dolatshad; Ayona T Silva; M Jill Saffrey
Journal:  Chem Cent J       Date:  2012-08-02       Impact factor: 4.215

Review 10.  Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration.

Authors:  Kunal Gupta; Siddharthan Chandran; Giles E Hardingham
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.